3 Underdog Stocks a Hedge Fund Manager Is Backing
A hedge fund manager challenges the winner-take-all fallacy in stocks. Discover three underdog stock picks poised to outperform in a concentrated market.
123 stories
A hedge fund manager challenges the winner-take-all fallacy in stocks. Discover three underdog stock picks poised to outperform in a concentrated market.
Bob Iger and Joshua Kushner project Lakers revenue doubling to $1.6B. Here's what their $30 billion valuation pitch reveals about sports as private equity.
A $1 trillion Medicaid cut over 10 years is coming. See which healthcare sectors and investor portfolios face the greatest exposure from new work requirements.
Citi warns of a two-speed economy where AI sectors surge while a hawkish Fed slows non-AI industries. Here's what it means for investors and growth.
The World Bank's private-capital mobilization now nearly equals its own lending. Discover what this strategic shift means for global development finance.
Investors are rushing back into rare-disease biotech stocks as FDA hard-liners exit. Here's what the regulatory shift means for orphan drug companies in 2026.
A new SVB collapse report commissioned by Fed Governor Michelle Bowman blames Biden-era supervisory staff, reigniting the debate over Federal Reserve banking oversight.
Walmart will sell Medicare Advantage plans via a nonprofit insurer partnership. Explore what this retail health shift means for seniors, insurers, and investors.
BlackRock's Rick Rieder sees opportunity in surging bond yields while Ray Dalio urges caution. Here's how six investing pros say you should trade treasuries now.
Social Security faces a projected $540 monthly benefit cut by 2033. Learn why most retirement portfolios are unprepared and what steps you can take now.
A death cross is forming on the US dollar index. Learn what this bearish technical signal means and why the White House may actually welcome a weaker USD.
Silver Lake takes Carl Icahn to court over the Endeavor buyout in a lawsuit with major M&A implications. Here's what investors need to know about the legal battle.